⚔️JHBPS Recent Paper⚔️ Advancement of Robo-assisted PD🤖with 630 cases🥇 RAPD is over 50% of all PD📈 in high-volume🏥 📈Aging🧓& chemo 💊 👉Indication of Robo & Open is important! onlinelibrary.wiley.com/journal/186869…

How to Predict Recurrence After Resection of Hepatocellular Carcinoma | Anticancer Research Mass General Surgery Mass General Cancer Center ar.iiarjournals.org/content/45/1/1…

Welcoming Dr. Vincenzo Villani to the Division of Transplant Surgery! #BIDMC # BILH #transplantsurgery

Exciting to share our last collaborative effort Cancer Immunology Research by Sun and Maggs et al. TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids Department of Surgery at Cedars-Sinai Mass General Cancer Center aacrjournals.org/cancerimmunolr…

In a new study, researchers from Mass General Cancer Center and colleagues investigated factors contributing to treatment resistance in CAR T therapies for solid tumors. Read more: massgeneral.org/news/research-… doi.org/10.1158/2326-6…

IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer | Nature nature.com/articles/s4158…

1/ JUST IN: an 8 year #kidneycancer journey now published in nature: “A personalized neoantigen vaccine generates anti-tumor immunity in high-risk renal cell carcinoma”. A trial of #RCC vaccine, led together with first author David Braun Yale Cancer Center and #PatrickOtt #DerinKeskin

TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids brnw.ch/21wQLiv russell.w.jenkins.mdphd

Long term outcomes - RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer | Nature ⁦Vinod BalachandranMD⁩ ⁦Memorial Sloan Kettering Cancer Center⁩ nature.com/articles/s4158…

Extremely honored to be invited for a grand round to Cedars-Sinai ! Thank you Dr Ferrone for your leadership and friendship! Very impressed from what you have done! CU Surgical Oncology CUpancreas

🚨🚨Out in nature, led by vincorbo: ecDNA is a major source of high-level focal amplification in key oncogenes and a major contributor of MYC heterogeneity in PDAC. MYC dosage affects cell morphology and dependence on stromal niche factors. nature.com/articles/s4158…

What about PNETs? #Pommier principles for resection of PNETs liver metastases at #AHPBA2025 To bookmark 🔖👇🏻

🚨PSA: the ALLIANCE A021806 for neoadjuvant vs adjuvant chemo in pancreas cancer is 4️⃣0️⃣ patients short of completing accrual Answer Dr Ferrone’s call: if each centre enrols 1️⃣ patient, enrolment will be complete! Lets do it! 💪

theguardian.com/books/2024/nov… nature.com/articles/s4159…

Congratulations to Dr. Xinhui Wang who has received a prestigious 4-year grant from the Department of Defense for her research project: “Development of Personalized Cancer Vaccines Targeting Tumor Heterogeneity and Reprogramming the Cold Tumor Microenvironment in Kidney Cancer.”

Nonoperative Management of Mismatch Repair–Deficient Tumors | New England Journal of Medicine nejm.org/doi/full/10.10…

If you’re a GI/HPB surgeon/oncologist who couldn’t make it to ASCO 2025 & trying to scour for its ongoings online like I have been, here’s the 2 trials you’d probably be interested in with a concise breakdown: MATTERHORN, & CASSANDRA! (Also tagging ppl who are smarter than me)

Please join us in congratulating Dr. Alexandra Gangi as our new Division Director of Surgical Oncology in the Jim and Eleanor Randall Department of Surgery! 🎉👏👏👏 Alexandra Gangi, MD Cristina Ferrone Cancer at Cedars-Sinai

Does TXA reduce blood transfusion within 7d after hepatectomy? The HeLiX Randomized Clinical Trial | Bleeding and Transfusion | JAMA | JAMA Network jamanetwork.com/journals/jama/…

Full article: Mature tertiary lymphoid structures linked to HPV status and anti-PD-1 based chemoimmunotherapy response in head and neck squamous cell carcinoma tandfonline.com/doi/full/10.10…